Cargando…
Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography
Background: Non-contrast computed tomography (CT) is frequently used to assess non-alcoholic/metabolic fatty liver disease (NAFLD/MAFLD), which is associated with cardiovascular risk. Although liver biopsy is considered the gold standard for diagnosis, standardized scores and non-contrast computed t...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144343/ https://www.ncbi.nlm.nih.gov/pubmed/35628989 http://dx.doi.org/10.3390/jcm11102863 |
_version_ | 1784716025311264768 |
---|---|
author | Bardach, Constanze Morski, Leonie Mascherbauer, Katharina Donà, Carolina Koschutnik, Matthias Halavina, Kseniya Nitsche, Christian Beitzke, Dietrich Loewe, Christian Waldmann, Elisabeth Trauner, Michael Mascherbauer, Julia Hengstenberg, Christian Kammerlander, Andreas |
author_facet | Bardach, Constanze Morski, Leonie Mascherbauer, Katharina Donà, Carolina Koschutnik, Matthias Halavina, Kseniya Nitsche, Christian Beitzke, Dietrich Loewe, Christian Waldmann, Elisabeth Trauner, Michael Mascherbauer, Julia Hengstenberg, Christian Kammerlander, Andreas |
author_sort | Bardach, Constanze |
collection | PubMed |
description | Background: Non-contrast computed tomography (CT) is frequently used to assess non-alcoholic/metabolic fatty liver disease (NAFLD/MAFLD), which is associated with cardiovascular risk. Although liver biopsy is considered the gold standard for diagnosis, standardized scores and non-contrast computed tomography (CT) are used instead. On standard cardiac T1-maps on cardiovascular imaging (CMR) exams for myocardial tissue characterization hepatic tissue is also visible. We hypothesized that there is a significant correlation between hepatic tissue T1-times on CMR and Hounsfield units (HU) on non-contrast CT. Methods: We retrospectively identified patients undergoing a non-contrast CT including the abdomen, a CMR including T1-mapping, and laboratory assessment within 30 days. Patients with storage diseases were excluded. Results: We identified 271 patients (62 ± 15 y/o, 49% female) undergoing non-contrast CT and CMR T1-mapping within 30 days. Mean hepatic HU values were 54 ± 11 on CT and native T1-times were 598 ± 102 ms on CMR and there was a weak, but significant, correlation between these parameters (r = −0.136, p = 0.025). On age and sex adjusted regression analysis, lower liver HU values indicated a dismal cardiometabolic risk profile, including higher HbA1C (p = 0.005) and higher body mass index (p < 0.001). In contrast, native hepatic T1-times yielded a more pronounced cardiac risk profile, including impaired systolic function (p = 0.045) and higher NT-proBNP values (N-Terminal Brain Natriuretic Peptide) (p = 0.004). Conclusions: Hepatic T1-times are easy to assess on standard T1-maps on CMR but only weakly correlated with hepatic HU values on CT and clinical NAFLD/MAFLD scores. Liver T1-times, however, are linked to impaired systolic function and higher natriuretic peptide levels. The prognostic value and clinical usefulness of hepatic T1-times in CMR cohorts warrants further research. |
format | Online Article Text |
id | pubmed-9144343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91443432022-05-29 Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography Bardach, Constanze Morski, Leonie Mascherbauer, Katharina Donà, Carolina Koschutnik, Matthias Halavina, Kseniya Nitsche, Christian Beitzke, Dietrich Loewe, Christian Waldmann, Elisabeth Trauner, Michael Mascherbauer, Julia Hengstenberg, Christian Kammerlander, Andreas J Clin Med Article Background: Non-contrast computed tomography (CT) is frequently used to assess non-alcoholic/metabolic fatty liver disease (NAFLD/MAFLD), which is associated with cardiovascular risk. Although liver biopsy is considered the gold standard for diagnosis, standardized scores and non-contrast computed tomography (CT) are used instead. On standard cardiac T1-maps on cardiovascular imaging (CMR) exams for myocardial tissue characterization hepatic tissue is also visible. We hypothesized that there is a significant correlation between hepatic tissue T1-times on CMR and Hounsfield units (HU) on non-contrast CT. Methods: We retrospectively identified patients undergoing a non-contrast CT including the abdomen, a CMR including T1-mapping, and laboratory assessment within 30 days. Patients with storage diseases were excluded. Results: We identified 271 patients (62 ± 15 y/o, 49% female) undergoing non-contrast CT and CMR T1-mapping within 30 days. Mean hepatic HU values were 54 ± 11 on CT and native T1-times were 598 ± 102 ms on CMR and there was a weak, but significant, correlation between these parameters (r = −0.136, p = 0.025). On age and sex adjusted regression analysis, lower liver HU values indicated a dismal cardiometabolic risk profile, including higher HbA1C (p = 0.005) and higher body mass index (p < 0.001). In contrast, native hepatic T1-times yielded a more pronounced cardiac risk profile, including impaired systolic function (p = 0.045) and higher NT-proBNP values (N-Terminal Brain Natriuretic Peptide) (p = 0.004). Conclusions: Hepatic T1-times are easy to assess on standard T1-maps on CMR but only weakly correlated with hepatic HU values on CT and clinical NAFLD/MAFLD scores. Liver T1-times, however, are linked to impaired systolic function and higher natriuretic peptide levels. The prognostic value and clinical usefulness of hepatic T1-times in CMR cohorts warrants further research. MDPI 2022-05-19 /pmc/articles/PMC9144343/ /pubmed/35628989 http://dx.doi.org/10.3390/jcm11102863 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bardach, Constanze Morski, Leonie Mascherbauer, Katharina Donà, Carolina Koschutnik, Matthias Halavina, Kseniya Nitsche, Christian Beitzke, Dietrich Loewe, Christian Waldmann, Elisabeth Trauner, Michael Mascherbauer, Julia Hengstenberg, Christian Kammerlander, Andreas Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography |
title | Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography |
title_full | Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography |
title_fullStr | Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography |
title_full_unstemmed | Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography |
title_short | Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography |
title_sort | comparison of hepatic tissue characterization between t1-mapping and non-contrast computed tomography |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144343/ https://www.ncbi.nlm.nih.gov/pubmed/35628989 http://dx.doi.org/10.3390/jcm11102863 |
work_keys_str_mv | AT bardachconstanze comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT morskileonie comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT mascherbauerkatharina comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT donacarolina comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT koschutnikmatthias comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT halavinakseniya comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT nitschechristian comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT beitzkedietrich comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT loewechristian comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT waldmannelisabeth comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT traunermichael comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT mascherbauerjulia comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT hengstenbergchristian comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography AT kammerlanderandreas comparisonofhepatictissuecharacterizationbetweent1mappingandnoncontrastcomputedtomography |